The immunobiology of systemic sclerosis

Area of Science:

• Immunology
• Rheumatology
• Pathogenesis of Systemic Sclerosis

Background:

• Systemic sclerosis (SSc) is a chronic connective tissue disease with vascular damage, autoimmunity, and fibrosis.
• Disease-targeted treatments for SSc remain elusive despite advances in other rheumatologic conditions.

Purpose of the Study:

• To review the contemporary immunobiology of Systemic Sclerosis (SSc) and its clinical implications.
• To synthesize current understanding of SSc pathogenesis from recent scientific literature.

Main Methods:

• A comprehensive literature search was conducted on PubMed from 1989 to 2007.
• Keywords used included "systemic sclerosis" and "reviews" to identify relevant publications.
• 259 articles focusing on recent advances in SSc pathogenesis were selected for this review.

Main Results:

• Key factors in SSc pathogenesis include T-cells, B-cells, fibroblasts, and cytokines/chemokines.
• T-cells show activation and antigen-driven expansion; oral tolerance induction shows clinical benefit.
• SSc fibroblasts exhibit a unique phenotype with excessive collagen production and cytokine dysregulation, maintained by autocrine signaling.

Conclusions:

• Systemic sclerosis (SSc) is a heterogeneous disease with complex immunopathogenesis.
• Identifying SSc T-cell antigens and key fibroblast regulators may lead to novel, targeted therapies.
• Further research into T-cell and fibroblast roles could yield new disease-modifying treatments for SSc.